EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS · Delayed Price · Currency is USD
336.00
+1.00 (0.30%)
At close: Dec 15, 2025
ESLOF Revenue
EssilorLuxottica Société anonyme had revenue of 14.02B EUR in the half year ending June 30, 2025, with 9.13% growth. This brings the company's revenue in the last twelve months to 27.24B, up 5.45% year-over-year. In the year 2024, EssilorLuxottica Société anonyme had annual revenue of 26.51B with 4.38% growth.
Revenue (ttm)
27.24B EUR
Revenue Growth
+5.45%
P/S Ratio
4.79
Revenue / Employee
177.47K EUR
Employees
153,498
Market Cap
153.21B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.51B | 1.11B | 4.38% |
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |
EssilorLuxottica Société anonyme News
- 6 hours ago - Analysts say a luxury eyewear giant could be the next AI winner - CNBC
- 3 days ago - EssilorLuxottica To Acquire Signifeye To Bolster Presence In Belgium - Nasdaq
- 3 days ago - EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint - GlobeNewsWire
- 5 days ago - EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear - GlobeNewsWire
- 5 days ago - Ray-Ban Meta Glasses Leads AI Eyewear Market But Face Competition Test - NDTV
- 6 days ago - EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025 - GlobeNewsWire
- 6 days ago - Focus: Ray-Ban Meta glasses take off but face privacy and competition test - Reuters
- 6 days ago - Meta Holds About 3% Stake In EssilorLuxottica: Reports - Nasdaq